Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD-like receptor family CARD domain-containing 5.
Wada A, Hirohashi Y, Kutomi G, Murata K, Iwabuchi S, Mizue Y, Murai A, Kyuno D, Shima H, Minowa T, Sasaki K, Kubo T, Kanaseki T, Tsukahara T, Nakatsugawa M, Hashimoto S, Osanai M, Torigoe T, Takemasa I.
Wada A, et al. Among authors: minowa t.
Cancer Sci. 2023 Dec;114(12):4511-4520. doi: 10.1111/cas.15986. Epub 2023 Nov 22.
Cancer Sci. 2023.
PMID: 37991442
Free PMC article.